Decisions for issue Brighton and Hove Cancer Strategy 2017-2020

1)           That the Board is asked to approve the Cancer Strategy.

2)           That the Board agrees to receive an update including an estimate of the strategy’s predicted impact on clinical and financial outcomes, including a sensitivity analysis, at the March 2018 meeting.